Product Information
TELMISARTAN 80 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1563 per EA under NDC 67877048430. Its NADAC has been published 351 times since Dec 4, 2019.
FDA first approved this application on Oct 30, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
80 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877048430
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA205150FDA Approved
10/30/2015
TE Code
AB
On Market Since
6/12/2016
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN 80 MG TABLET has been published 351 times since Dec 4, 2019, and over the history we have for it it has declined 71.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1563 per EA |
|---|---|
| All-time high | $0.6664 (Mar 11, 2020) |
| All-time low | $0.1345 (May 22, 2024) |
| 52-week high | $0.1634 |
| 52-week low | $0.1473 |
| Median price | $0.2590 |
| Average price | $0.2921 |
| Largest weekly change | +53.7% (Nov 22, 2023) |
| Weeks tracked | 351 |
| Tracking since | Dec 4, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TELMISARTAN 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 80 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.1563 per EA (NDC 67877048430), effective Aug 19, 2026.
How has the price of TELMISARTAN 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for TELMISARTAN 80 MG TABLET has declined 71.6%. It has been tracked across 351 weekly CMS publications since Dec 4, 2019.
What are the highest and lowest recorded NADAC prices for TELMISARTAN 80 MG TABLET?
Since Dec 4, 2019, the NADAC for TELMISARTAN 80 MG TABLET has ranged from a low of $0.1345 (May 22, 2024) to a high of $0.6664 (Mar 11, 2020), with a median of $0.2590 per EA.
Are there cheaper alternatives to TELMISARTAN 80 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TELMISARTAN 80 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TELMISARTAN 80 MG TABLET?
TELMISARTAN 80 MG TABLET (NDC 67877048430) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.